Two paraneoplastic syndromes in a patient with ovarian cancer: Nephrotic syndrome and paraneoplastic cerebellar degeneration

Gynecologic Oncology

Volumn 80, Issue 1, 2001, Pages 96-98

  Forgy, Andrea P ^a   Ewing, Thomas L ^b   Flaningam, John ^b  

^a KAISER PERMANENTE   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; PACLITAXEL; PREDNISONE;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CASE REPORT; CEREBELLUM DEGENERATION; DISEASE ASSOCIATION; FEMALE; GYNECOLOGIC CANCER; HUMAN; NEPHROTIC SYNDROME; NEUROLOGICAL COMPLICATION; OVARY CANCER; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY;

EID: 0035172309     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.6029     Document Type: Article

References (11)

1. The association of cancer and the nephrotic syndrome
2. Paraneoplastic cerebellar degeneration
3. Ovarian cancer associated with the nephrotic syndrome
4. Membranous nephropathy associated with ovarian tumour in a young girl: Recovery after removal
5. Systemic amyloidosis and ovarian carcinoma
6. Tumor-related renal lesions: Reversal following tumor excision
7. Glomerulopathies of neoplasia
8. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: Case report and review of the literature
9. Normalization of the tumor marker CA-125 after oophorectomy in a patient with paraneoplastic cerebellar degeneration without detectable cancer
10. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients
11. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume